Abstract
Introduction
Major histocompatibility complex (MHC) antigens play a central role in interactions within immune cells and between cytotoxic lymphocytes and tumor cells (Zinkernagel and D o h e r t y, 1979; Karre et al., 1986; Saxena, 1997) . Factors which modulate expression of MHC antigens can be potent immunomodulators. Many factors including interferon (Piontek et al., 1985; Wiebke et al.,1990) , phorbol esters and sodium butyrate (Dokhelar et al., 1982 (Dokhelar et al., ,1984 , are known to augment class I MHC expression on tumor cells. Work from our laboratory has described a putative novel cytokine termed MHC augmenting factor (MHC-AF), which enhances the class I MHC expression on tumor cells and renders them resistant to NK lysis (Saxena, 1987; Saxena et al., 1988 Saxena et al., , 1989 Saxena et al., , 1992 Saxena et al., , 1996 Puri, 1995; Raval et al., 1997) . Interferon γ (IFN-γ) has activities similar to M H C -A F, and since it is also produced by mitogen activated lymphocytes, it is possible that the MHC-AF is same as IFN-γ. Biological and biochemical properties of M H C -A F, however, strongly suggest that it is distinct from IFN-γ (Saxena et al., 1987 (Saxena et al., , 1988 (Saxena et al., , 1992 . MHC-AF unlike IFN-γ, is resistant to pH 2 treatment and lacks anti-viral activity (Dokhelar et al., 1984; Saxena et al. , 1988) . While the final proof of MHC-AF being diff e r e n t from IFN-γ will come when the former is purified to h o m o g e n e i t y, this has posed problem since MHC-AF is produced in extremely low quantities which makes its purification difficult. We have devised purification schemes utilizing liquid chromato-graphy, isoelectric focusing and ionexchange and reverse phase HPLC steps, but MHC-AF has not yet been purified to homogeneity (Saxena, 1987; Saxena et al., 1988 Saxena et al., , 1992 Saxena et al., , 1996 Raval et al., 1997) . Recently, we have isolated a MHC-AF activity from culture supernatants of murine spleen cells activated by mitogen or in a mixed lymphocyte reaction (Saxena et al., 1992; Puri, 1995) . Having obtained MHC-AF preparations from two species, we have explored the species specificity of the biological activity of MHC-AF and compared it from that of IFN-γ. Our results indicate a major difference in species specificities between MHC-AF and IFN-γ.
Materials and Methods

Culture medium
Tumor cell lines were maintained in RPMI 1640 from Sigma (St. Louis, MO), supplemented with 5% fetal calf serum, 20 µM 2-mercaptoethanol, 300 µg/ml glutamine, and 60 µg/ml gentamicin (complete medium). For generation of M H C -A F, the lymphocyte cultures were carried out in commercially available serum free medium, DCCM-2 from Biological Industries, Israel, supplemented with 20 µM 2-mercaptoetharol, 300 µg/ml glutamine and 60 µg/ml gentamicin. 
Monoclonal antibodies and antibody c o n j u g a t e s
Supernatants from hybridoma cell lines B468 (secreting a n t i -H -2 K k ), B896 (secreting anti-H-2K b ) and HB95 (secreting anti-HLA-A, B and C ) were used as sources of monoclonal antibodies. Hybridoma cell lines B486 and B896 were kindly provided by Dr. Eli Gorelik of the Pittsburgh Cancer Institute and hybridoma HB95 was obtained from ATCC (Rockville, MD, USA). Goat antimouse Ig-FITC from Gibco BRL was used as second antibody in flow cytometric studies.
Tumor cell lines
Murine tumor cell lines EL-4 (haplotype H-2 b , from AT C C , TIB39) and BW5147 (haplotype H-2 k , from ATCC, TIB47) are T cell lymphomas originally obtained from NIA, NIH (courtesy of Dr. W. H. Adler). Human tumor cell lines, K562, a chronic myelogenous leukemia (ATCC, CCL 243) was also obtained from NIA, NIH, and HR7, a gastric carcinoma cell line was originally obtained from Pittsburgh Cancer Institute (courtesy of Dr. T. L. Whiteside).
Preparation of MHC-AF
Human MHC-AF was purified from the culture supernatant of human peripheral blood lymphocytes (HPBLs) activated by concanavalin A (Con-A), as described before (Saxena et al., 1996; Raval et al., 1997) . Mouse MHC-AF preparations were derived from culture supernatants of mouse spleen cells activated in a mixed lymphocyte reaction (Saxena et al., 1981) , by using the purification scheme utilized for rat MHC-AF (Saxena et al., 1988) . Human MHC-AF has previously been shown to lack any IFN like anti-viral activity (Saxena et al., 1996) . Murine MHC-AF preparations were also devoid of any anti-viral activity assessed by using a L-cells VSV system of IFN bioassay (Saxena et al., 1988) .
Estimation of cell surface antigen on tumor cell lines
The tumor cells in culture were treated with IFN-γ (500 U/ml) or MHC-AF preparations (50 µg /ml) for 2 to 3 day, and stained for class I MHC antigens as described before (Saxena et al ., 1988 (Saxena et al ., , 1996 Raval et al., 1997) . Briefly, control or treated tumor cells were suspended in 50 µl of hybridoma supernatants containing relevant anti-MHC class I antibodies and incubated for 20 min at 4˚C. Cells were washed once with cold phosphate-buffered saline (PBS) and suspended in 50 µl of goat anti-mouse immunoglobulin FITC at 1:400 dilution. After 20 min. incubation at 4˚C, cells were washed once with cold PBS and fixed in 0.5 ml of 1% (w/v) paraformaldehyde in PBS. Stained and fixed cells were analyzed in a Coulter Epics-XL flow cytometer.
Results
Effect of recombinant IFN-and MHC-AF on the expression of MHC class I antigens on two murine tumor cell lines
EL4 and BW5147 murine cell lines were treated with mouse or human IFN-γ or with human or mouse MHC-AF preparations for two days, and stained for expression of MHC class I antigens. Results of flow cytometric analysis in Figure 1 show that mouse IFN-γ induced significant increase in the expression of class I MHC antigens on both mouse tumor lines, whereas human IFN-γ failed to have any effect on MHC I expression. Both human as well as mouse MHC-AF however increased MHC class I antigen expression on both tumor cell lines.
Effect of recombinant IFN-and MHC-AF on the expression of MHC class I antigens on two human tumor cell lines
K562 and HR7 human tumor cell lines were treated with mouse or human IFN-γ or with human or mouse MHC-AF preparations for two days, and stained for expression of MHC class I antigens. Results of flow cytometric analysis in Figure 2 show that mouse IFN-γ as well as mouse MHC-AF had no effect on the expression of class I MHC antigens on both K562 and HR7 tumor lines. Human I F N -γ as well as human MHC-AF, however, increased MHC class I antigen expression on both tumor cell lines.
These results indicate that the biological activity of I F N -γ is strictly species specific since mouse and human I F N -γ acted on mouse and human cell lines only. In case o f M H C -A F, however, mouse MHC-AF was species specific in action whereas human MHC-AF was biologically active on both mouse and human cell lines.
Discussion
We have previously reported partial purification and characterization of a rat MHC-AF (Saxena, 1987; Saxena et al ., 1988) . The rat factor is a 12-kDa protein with an isoelectric pH of 4.8 (Saxena et al., 1988) . Recently, partial purification and characterization of human MHC-AF has also been reported and it appears to be a 30-kDa protein with pI of 6.0 (Saxena et al., 1996; Raval et a l., 1997) . Using the purification scheme standardized for rat MHC-AF, we have now been able to partially purify a mouse MHC-AF from culture supernatants of mouse spleen cells activated in mixed lymphocyte reaction (Puri, 1995) . Human and mouse MHC-AF are assayed by their e ffect on the expression of MHC class I antigens o n human and mouse tumor cell lines respectively. Since IFN-γ is also active in MHC-AF assays and activated T lymphocytes (e.g. in mitogen activated spleen cells and in mixed lymphocyte reaction) produce IFN-γ, that raises the question whether MHC-AF is identical to IFN-γ o r somehow related to IFN-γ. Based upon biological, immunological and biochemical characterization of MHC-AF preparations, we feel convinced that MHC-AF is a new cytokine distinct from IFN-γ (Saxena, 1987; et al., 1988 , 1989 , 1992 , 1996 Puri, 1995; Raval et al., 1997) . Final confirmation of a distinct identity of MHC-AF wll come when this factor is purified to homogeniety and its structure determined. Since MHC-AF is produced in extremely small quantities, its final purification is yet to be achieved. In our present study, we have used partially purified MHC-AF preparations from mouse and human sources. These MHC-AF preparations were, h o w e v e r, devoid of any IFN-γ contamination as assessed by anti-viral bioassay of IFN. We tested for the augmentation of MHC class I expression on two mouse and two human tumor cell lines in response to IFN-γ and MHC-AF from the two species. While both mouse and human IFN-γ and mouse MHC-AF were strictly species specific in their biological activities, human MHC-AF acted in a species non-specific way, since it increased the MHC class I expression on both mouse and human cell lines. Differences in the species specificity patterns of MHC-AF and IFN-γ provide an important fresh evidence which indicate that the two mediators are distinct from each other.
